Central Drugs Standard Control Organisation Issues Advisory Against Promotion of GLP-1 Drugs for Obesity Through Surrogate Advertising
India’s drug regulator Central Drugs Standard Control Organisation warns pharmaceutical firms against direct or indirect promotion of prescription-only GLP-1 drugs for obesity, stressing strict compliance with the Drugs and Cosmetics Act, 1940.
- Industrial talks | 13/03/2026 | By News Bureau
Interviews
Shivani Wagh, Joint MD, Supriya Lifescience
On the eve of Women’s Day, Shivani Wagh, Joint MD, Supriya Lifescience, speaks to Dorina Bhattacharjee about leadership, global expansion, building inclusive teams, and advancing opportunities for women in the...
Sunil Dubey, Managing Director, SOTAX India
Sunil Dubey, Managing Director, SOTAX India, in an interview with Pharma Industrial India, highlighted the company’s initiatives in India, including affordable quality machinery for small manufacturers, advanc...
Andrew Gent, Head of Sales - Middle East and Asia, ChargePoint Technology
Andrew Gent, Head of Sales – Middle East & Asia at ChargePoint Technology, speaks to Pharma Industrial India about advancing containment, sterility and operator safety in pharmaceutical production, highlig...
Articles
Why Manufacturing Discipline is Becoming a True Differentiator in Generic Pharmaceuticals
Discipline has become the real competitive advantage in generic pharmaceuticals, overtaking scale, speed and low cost as the main drivers of success....
Sustainable Manufacturing for Pharma: Economic and Environmental Impact of Single-Use Systems
Falgun Jani, Business Head – India, Freudenberg Medical, explores the growing role of Single-use Systems (SUS) in enabling sustainable pharmaceutical manufacturing, highlighting their economic advantages, oper...
From Reactive Care to Predictive Pharma: Indian AI Shift by 2026
India’s pharmaceutical industry is transitioning from a reactive, volume-driven model to a predictive, AI-powered ecosystem—highlighting the role of agentic AI, smart manufacturing, resilient supply chai...
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Industrial talks
- - Symbiosis Pharmaceutical Services Appoints Joanne Anderson as Chief Commercial Officer
- - Mankind Pharma Urges Greater Kidney Health Awareness as CKD Burden Rises
- - Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities
- - AI Imaging Biomarker Shows Promise in Predicting Immunotherapy Response in Non-Small Cell Lung Cancer Patients
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy